Corporate
Olema Oncology CFO Kovacs Exits Ahead of Phase 3 Data, Sold $3M in Shares Weeks Before Departure
Jan 30
You're signed outSign in or to get full access.
OP
Olema Pharmaceuticals (OLMA)·Earnings Reports
Q4 2024
View earnings summary and analysis
Q3 2024
View earnings summary and analysis
Q2 2024
View earnings summary and analysis
Q1 2024
View earnings summary and analysis
Research analysts covering Olema Pharmaceuticals.